Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Denmark

Marie Skłodowska-Curie Action · Running

CASTedit Repurposing the CRISPR-associated transposons (CAST) system for gene editing applications

Coordinator
Kobenhavns Universitet, Denmark
Runs
1 May 2025 to 30 April 2027
Status
Running
EU funding
€248k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101208401

What the project is doing

In the project's own words, from its summary on CORDIS.

The rapid advancements in CRISPR-Cas technology have revolutionized gene editing, yet significant challenges persist, particularly the reliance on DNA Damage Response (DDR) pathways and the limitations in integrating large DNA segments. These constraints hinder the application of CRISPR-Cas systems, especially in non-dividing cells and complex genomic modifications. The recently discovered CRISPR-associated transposon (CAST) systems offer a transformative solution, enabling the insertion of large DNA cargos (10–30 kb) into specific genomic locations without inducing double-strand breaks (DSBs), thereby providing a safer and more versatile genome-editing tool.

The CASTedit project aims to repurpose CAST systems as next-generation genome editing tools, with a focus on mammalian cells. Specific objectives include the development of engineered CAST systems (Types V-K and I-D) for precise DNA integration, the exploration of novel CAST complexes for RNA-guided transposition, and their validation at the organismal level. Successful implementation of these systems in eukaryotic cells could overcome current CRISPR limitations, paving the way for innovative applications in cell engineering, regenerative medicine, and biotechnology.

Under the guidance of Prof. Guillermo Montoya, a leading expert in the structure-function analysis of nucleases, and with his pioneering research in CAST complex assembly at the University of Copenhagen, I will be well-positioned to achieve the goals of this project. I will leverage my expertise in CRISPR-based genome editing, protein expression systems in eukaryotes, and high-throughput mutant screening to optimize CAST systems for precise DNA integration in mammalian cells.

The successful execution of CASTedit will establish me as a prominent researcher in genome engineering, utilizing the host institution’s state-of-the-art facilities and collaborative environment to drive innovation in therapeutic applications.

Topics

Who is involved

OrganisationCityCountryRole
Kobenhavns UniversitetKobenhavnDenmarkCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI